BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 24076634)

  • 21. A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory.
    Singh A; Suresh M
    J Leukoc Biol; 2007 Nov; 82(5):1201-11. PubMed ID: 17704295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of hypoxia-inducible factor-2 in adipocytes results in pathological cardiac hypertrophy.
    Lin Q; Huang Y; Booth CJ; Haase VH; Johnson RS; Celeste Simon M; Giordano FJ; Yun Z
    J Am Heart Assoc; 2013 Dec; 2(6):e000548. PubMed ID: 24326162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.
    Staron MM; Gray SM; Marshall HD; Parish IA; Chen JH; Perry CJ; Cui G; Li MO; Kaech SM
    Immunity; 2014 Nov; 41(5):802-14. PubMed ID: 25464856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Hypoxia Signaling in Stromal Progenitors Impairs Kidney Development.
    Gerl K; Steppan D; Fuchs M; Wagner C; Willam C; Kurtz A; Kurt B
    Am J Pathol; 2017 Jul; 187(7):1496-1511. PubMed ID: 28527294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease.
    Wang J; Lu Z; Xu Z; Tian P; Miao H; Pan S; Song R; Sun X; Zhao B; Wang D; Ma Y; Song X; Zhang S; Liu L; Jiang H
    Sci Rep; 2017 Jan; 7():41038. PubMed ID: 28112200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified Hypoxia-Inducible Factor Expression in CD8
    Veliça P; Cunha PP; Vojnovic N; Foskolou IP; Bargiela D; Gojkovic M; Rundqvist H; Johnson RS
    Cancer Immunol Res; 2021 Apr; 9(4):401-414. PubMed ID: 33602720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade.
    Shah YM; Ito S; Morimura K; Chen C; Yim SH; Haase VH; Gonzalez FJ
    Gastroenterology; 2008 Jun; 134(7):2036-48, 2048.e1-3. PubMed ID: 18439915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells.
    Razorenova OV; Castellini L; Colavitti R; Edgington LE; Nicolau M; Huang X; Bedogni B; Mills EM; Bogyo M; Giaccia AJ
    Mol Cell Biol; 2014 Feb; 34(4):739-51. PubMed ID: 24344197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis.
    Mastrogiannaki M; Matak P; Mathieu JR; Delga S; Mayeux P; Vaulont S; Peyssonnaux C
    Haematologica; 2012 Jun; 97(6):827-34. PubMed ID: 22207682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cytotoxic T lymphocyte efficacy in acute and persistent lymphocytic choriomeningitis virus infection.
    Graw F; Richter K; Oxenius A; Regoes RR
    Proc Biol Sci; 2011 Nov; 278(1723):3395-402. PubMed ID: 21450739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrogen sulfide inhibits hypoxia- but not anoxia-induced hypoxia-inducible factor 1 activation in a von hippel-lindau- and mitochondria-dependent manner.
    Kai S; Tanaka T; Daijo H; Harada H; Kishimoto S; Suzuki K; Takabuchi S; Takenaga K; Fukuda K; Hirota K
    Antioxid Redox Signal; 2012 Feb; 16(3):203-16. PubMed ID: 22004513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.
    Mangiavini L; Merceron C; Araldi E; Khatri R; Gerard-O'Riley R; Wilson TL; Sandusky G; Abadie J; Lyons KM; Giaccia AJ; Schipani E
    Am J Pathol; 2015 Nov; 185(11):3090-101. PubMed ID: 26348575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
    Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
    PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein.
    Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C
    Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response.
    Hwang II; Watson IR; Der SD; Ohh M
    J Virol; 2006 Nov; 80(21):10712-23. PubMed ID: 16928739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
    Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI
    J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma.
    Maranchie JK; Zhan Y
    Cancer Res; 2005 Oct; 65(20):9190-3. PubMed ID: 16230378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of PKR and Type I IFNs in viral control during primary and secondary infection.
    Nakayama Y; Plisch EH; Sullivan J; Thomas C; Czuprynski CJ; Williams BR; Suresh M
    PLoS Pathog; 2010 Jun; 6(6):e1000966. PubMed ID: 20585572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.